IBDEI348 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49762,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,49762,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,49762,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,49763,0)
 ;;=I67.89^^193^2482^16
 ;;^UTILITY(U,$J,358.3,49763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49763,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,49763,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,49763,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,49764,0)
 ;;=J45.909^^193^2482^4
 ;;^UTILITY(U,$J,358.3,49764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49764,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,49764,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,49764,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,49765,0)
 ;;=J44.9^^193^2482^14
 ;;^UTILITY(U,$J,358.3,49765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49765,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,49765,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,49765,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,49766,0)
 ;;=K21.9^^193^2482^29
 ;;^UTILITY(U,$J,358.3,49766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49766,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,49766,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,49766,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,49767,0)
 ;;=N40.1^^193^2482^27
 ;;^UTILITY(U,$J,358.3,49767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49767,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,49767,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,49767,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,49768,0)
 ;;=L03.818^^193^2482^15
 ;;^UTILITY(U,$J,358.3,49768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49768,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,49768,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,49768,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,49769,0)
 ;;=G47.33^^193^2482^75
 ;;^UTILITY(U,$J,358.3,49769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49769,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,49769,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,49769,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,49770,0)
 ;;=R73.01^^193^2482^44
 ;;^UTILITY(U,$J,358.3,49770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49770,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,49770,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,49770,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,49771,0)
 ;;=R74.8^^193^2482^1
 ;;^UTILITY(U,$J,358.3,49771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49771,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,49771,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,49771,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,49772,0)
 ;;=R03.0^^193^2482^25
 ;;^UTILITY(U,$J,358.3,49772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49772,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,49772,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,49772,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,49773,0)
 ;;=Z91.19^^193^2482^51
 ;;^UTILITY(U,$J,358.3,49773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49773,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,49773,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,49773,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,49774,0)
 ;;=E66.01^^193^2482^52
 ;;^UTILITY(U,$J,358.3,49774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49774,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,49774,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,49774,2)
 ;;=^5002826
